Ambulances delays lead Wilmslow GPs to drive patient to A&E
Two Wilmslow doctors say the NHS is “broken” after they had to drive a patient to A&E themselves.
Similar Posts
Captain Sir Tom Moore: What has happened to his legacy?
How much money did Captain Tom raise and why is his family under the spotlight?
Florida wins first FDA approval to import cheaper drugs from Canada
Pharmacist Thomas Jensen looks over a prescription drug at the Rock Canyon Pharmacy in Provo, Utah, on May 9, 2019. George Frey | Reuters The U.S. Food and Drug Administration on Friday approved Florida’s plan to import cheaper prescription drugs from Canada, a first-in-the-nation move that could reduce costs for Americans but faces fierce opposition…
Crafting Your Home Workout Routine: A Guide to Fitness at Your Fingertips
In the age of digital connectivity and home-centric lifestyles, establishing a home workout routine has become more than a convenience—it’s a cornerstone of maintaining physical and mental health for many. Whether you’re avoiding the commute to the gym, saving on membership fees, or simply prefer the privacy of your own space, a home workout routine…
Birmingham Children's Hospital isolating measles patients
A&E consultant Chris Bird said the measures felt like going “back to Covid” in some ways.
Gilead stock falls after lung cancer study results disappoint
Sopa Images | Lightrocket | Getty Images Shares of Gilead fell more than 10% on Monday after a key drug from the company did not significantly extend the lives of patients with a certain lung cancer in a late-stage trial. The results are a blow to Gilead, which is working to become a power player…
Zepbound is off to a strong start, but here’s what Eli Lilly investors are watching
Hopes are sky-high for Eli Lilly’s recently launched weight loss drug Zepbound. Investors will be tuning into the company’s fourth quarter earnings call on Feb. 6, eager to hear more about how that rollout is going. One key statistic will be the number of commercial health insurers providing coverage of the drug, which was approved…